In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the ...

Strokes are the fifth-leading cause of death in the United States, and the leading cause of disability. On Monday, the ...

Schizoaffective disorder is a chronic mental health condition characterized by symptoms of both schizophrenia and mood ...

Many people on social media are recommending a combination of supplements—magnesium and L-theanine—for better sleep. Experts ...

Authors randomly allocated 1,385 participants to four groups --- 551 to GMRx2, 276 to telmisartan–indapamide, 282 to telmisartan–amlodipine, and 276 to amlodipine–indapamide groups ...

Although a combination of certain pain medications has been found to be more effective than opioids alone at managing ...

There are several types of GLP-1 medications available, each with varying dosing schedules and forms of administration. Some ...

While recovering from major surgery, Black patients may be less likely to receive certain multimodal analgesia options and more likely to receive oral opioids than white patients, according to ...

New drugs for the lung disease are allowing people to live much longer with the condition, which historically was often fatal ...

Phase III trial results of novel triple combination pill for hypertension published in The LancetNovel combination pill significantly reduced ...

FDA approval: Ozempic is FDA-approved for Type 2 diabetes, while Wegovy is FDA-approved for weight loss. Cost: Ozempic is ...

Newer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according to a study presented at the American College of Surgeons (ACS) Clinical ...